The global Sacral Neuromodulation Market reached a valuation of USD 1.03 billion in 2022 and is poised to ascend to USD 1.85 billion by the year 2032, exhibiting an impressive compound annual growth rate (CAGR) of 6.8% throughout the forecast period. This upward trajectory is fueled by a confluence of factors, including the escalating prevalence of Overactive Bladder Syndrome (OA, fecal incontinence, and chronic pelvic discomfort.
https://www.reportsanddata.com..../report-detail/sacra
Like
Comment
Share
